Stay updated on MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial

Sign up to get notified when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting and layout adjustments; there are no changes to core study details like eligibility criteria, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:29:37.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and updated version to v3.2.0; - Removed the resource on Mature T-cell and NK-cell non-Hodgkin lymphoma (GRDIC).
    Difference
    3%
    Check dated 2025-10-06T06:59:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:42:48.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Updated page version from v3.0.1 to v3.0.2, signaling a new release with unspecified fixes or enhancements. Removed the 'Back to Top' link, a minor navigation cleanup.
    Difference
    0.2%
    Check dated 2025-09-14T21:38:51.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T17:58:02.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as specific medical terms related to non-Hodgkin lymphoma and associated treatments. Notably, the previous versions of certain drugs have been removed, indicating a potential shift in focus or content relevance.
    Difference
    3%
    Check dated 2025-08-31T12:15:31.000Z thumbnail image

Stay in the know with updates to MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-3475 Combo with Copanlisib in NK/T-cell NHL Clinical Trial page.